Raintree Systems Accelerates Innovation and Growth with Strategic Appointment to Board of Directors

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

30-Year Tech and Healthcare Veteran, Bill Lucchini, to Advise on Driving Customer Value Through Automation and Efficiency

CHANDLER, Ariz., Sept. 27, 2024 /PRNewswire/ — Raintree Systems, inc., a leading rehabilitation therapy software provider backed by Serent Capital, announced today the appointment of Bill Lucchini to its Board of Directors.

This strategic addition comes at a pivotal time as Raintree continues its rapid growth and solidifies its position as a leader in technology solutions for physical therapy, occupational therapy, speech-language pathology, and multidisciplinary therapy practices.

Lucchini brings an outstanding track record in scaling healthcare technology solutions. As CEO of Nextech Systems, a prominent healthcare technology solution for specialty providers, Lucchini focused on customer-centric innovation that led to the company being the preeminent EHR and payments solutions in its specialties. Lucchini’s emphasis on creating meaningful workflow and efficiency benefits for its customers included AI-empowered patient journey innovations. He has also served as CEO of Dealer-FX Group, Inc., SVP and GM of Sophos Cloud, COO at OnForce, and held an impressive 16-year tenure at Intuit. His experience and expertise will help advise and accelerate Raintree’s product roadmap.

“We are thrilled to attract a leader of Bill’s caliber to our Board,” said Nick Hedges, CEO of Raintree Systems. “He is renowned for transforming Nextech through product innovation, including AI, that reset the bar for customer value. I am excited for the Board and I to have Bill as a close advisor as we chart a similar path at Raintree to redefine innovation in the rehab therapy EHR space.”

“I’m excited to work with Nick, the board, and the executive team to further Raintree’s mission to help therapy professionals provide better care and achieve superior outcomes for their patients,” said Lucchini. “Therapy professionals are making a difference for patients every day, and as an industry leader Raintree drives innovation that helps them focus on patient care while enabling them to grow and thrive. I look forward to working with all the great people at Raintree to leverage AI and other new technologies to do even more for our customers.”

About Raintree Systems 
Raintree is the preeminent platform for enterprise and mid-sized therapy provider organizations. With a proven track record of success and client satisfaction, Raintree provides solutions in patient engagement and communications, clinical documentation, revenue cycle management (RCM), and business intelligence/analytics for adult and pediatric physical therapy, occupational therapy, speech therapy, and multidisciplinary practices across all treatment settings. Raintree clients make up over 2,500 implementations nationwide and more than 25,000 users daily. Raintree leads the industry in compliance and security, offering the first ONC-certified EHR designed specifically for rehabilitation therapy. To learn more about Raintree, visit https://www.raintreeinc.com/

Contact: 
Sorella Andersen
sorella.andersen@raintreeinc.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/raintree-systems-accelerates-innovation-and-growth-with-strategic-appointment-to-board-of-directors-302261383.html

SOURCE Raintree Systems

Staff

Recent Posts

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

Company to also highlight advancements in denials and underpayments management and speak to the measurable…

7 hours ago

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

Next generation analyzer helps hospitals protect revenue before it's lost by delivering timely end-to-end visibility…

7 hours ago

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction…

10 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows

Dr. Anosh Ahmed repurposes West Side warehouse into blockchain innovation center, targeting 250+ jobs and…

10 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift

Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs…

10 hours ago

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits…

10 hours ago